Inactivation of lipid-enveloped viruses in proteins by caprylate.
about
Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma.Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies.Oleic acid inhibits stearic acid-induced inhibition of cell growth and pro-inflammatory responses in human aortic endothelial cells.Pathogen safety of manufacturing processes for biological products: special emphasis on KOGENATE Bayer.Safety of snake antivenom immunoglobulins: efficacy of viral inactivation in a complete downstream process.Development and scale-up of the recovery and purification of a domain antibody Fc fusion protein-comparison of a two and three-step approach.
P2860
Inactivation of lipid-enveloped viruses in proteins by caprylate.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Inactivation of lipid-enveloped viruses in proteins by caprylate.
@en
Inactivation of lipid-enveloped viruses in proteins by caprylate.
@nl
type
label
Inactivation of lipid-enveloped viruses in proteins by caprylate.
@en
Inactivation of lipid-enveloped viruses in proteins by caprylate.
@nl
prefLabel
Inactivation of lipid-enveloped viruses in proteins by caprylate.
@en
Inactivation of lipid-enveloped viruses in proteins by caprylate.
@nl
P1433
P1476
Inactivation of lipid-enveloped viruses in proteins by caprylate.
@en
P2093
J L Lundblad
P2860
P356
10.1111/J.1423-0410.1991.TB00878.X
P577
1991-01-01T00:00:00Z